News Moderna, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
102 ^USD	-1.39%		-4.68%	+2.56%

07:26am	China's drugmakers can't sell mRNA shots but haven't quit yet	RE
Apr. 16	Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	MT

China's drugmakers can't sell mRNA shots but haven't quit yet	01:26am	RE
Moderna : 2024 Proxy Statement	Apr. 16	PU
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing	Apr. 16	MT
Africa CDC's Statement On Moderna's Plan to Reassess Commitment to African Vaccine Manufacturing [press release]	Apr. 16	AQ
Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla...	Apr. 15
Market outlook is uncertain, but optimism prevails	Apr. 15
University of Oregon: Options can lower vaccine hesitancy for COVID-19, other diseases	Apr. 15	AQ
Moderna cancer vaccine shows promise in initial tests; share skyrockets	Apr. 12	AQ
Moderna Pauses Plans to Build Vaccines Facility in Kenya	Apr. 12	AQ
Moderna - Statement on Kenya Manufacturing Facility	Apr. 12	AQ
Redburn Adjusts Moderna's Price Target to $117 From $110	Apr. 12	MT
Moderna pauses Kenya plant plans as COVID vaccine demand wanes	Apr. 11	RE
Moderna Pausing Plan to Build Kenya Vaccine Production Plant	Apr. 11	MT
Moderna Reportedly Pausing Plan to Build Kenya Vaccine Production Plant	Apr. 11	MT
Moderna Reportedly Putting Plan for Kenya Vaccine Plant on Hold	Apr. 11	MT
Moderna puts Kenya plant plans on hold as COVID vaccine demand slumps	Apr. 11	RE
Moderna : Statement on Kenya Manufacturing Facility	Apr. 11	PU
Health Care Down on Retreat From Risk -- Health Care Roundup	Apr. 10	DJ
U.S. stocks inch mostly higher ahead of CPI data	Apr. 09	RE
Health Care Stocks Steady, Moderna Climbs -- Health Care Roundup	Apr. 09	DJ

No results for this search

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector